Cell Line : KMS-28BM
Cellosaurus Index : CVCL_2994
Cellosaurus ID : KMS-28BM
CCLE Name
: KMS28BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
CTRP2 Name
: KMS28BM
Cancer Type : haematopoietic_and_lymphoid_tissue
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| KMS-28BM | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-28BM | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | 3-Cl-AHPC | CTRP2 | 0.0041 | 66.0000 |
|
| KMS-28BM | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-28BM | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-28BM | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-28BM | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | AZD-7545 | CTRP2 | 0.0720 | 74.0000 |
|
| KMS-28BM | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-28BM | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| KMS-28BM | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-28BM | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | BRD-K02251932 | CTRP2 | 0.0320 | 66.0000 |
|
| KMS-28BM | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K04800985 | CTRP2 | 0.0081 | 66.0000 |
|
| KMS-28BM | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| KMS-28BM | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| KMS-28BM | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| KMS-28BM | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-28BM | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | BRD6430 | CTRP2 | 0.0160 | 33.0000 |
|
| KMS-28BM | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-28BM | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| KMS-28BM | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-28BM | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-28BM | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| KMS-28BM | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-28BM | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| KMS-28BM | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| KMS-28BM | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| KMS-28BM | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | compound 1B | CTRP2 | 0.0081 | 66.0000 |
|
| KMS-28BM | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Crizotinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Cyclophosphamide | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-28BM | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| KMS-28BM | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-28BM | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-28BM | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0030 | 50.0000 |
|
| KMS-28BM | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| KMS-28BM | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Erlotinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| KMS-28BM | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| KMS-28BM | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-28BM | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-28BM | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | GMX-1778 | CTRP2 | 0.0000 | 0.2900 |
|
| KMS-28BM | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-28BM | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| KMS-28BM | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | isoevodiamine | CTRP2 | 0.0041 | 33.0000 |
|
| KMS-28BM | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| KMS-28BM | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| KMS-28BM | IU1 | CTRP2 | 0.0020 | 33.0000 |
|
| KMS-28BM | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-28BM | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-28BM | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | KHS101 | CTRP2 | 0.0041 | 66.0000 |
|
| KMS-28BM | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-28BM | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | LE-135 | CTRP2 | 0.0020 | 4.2000 |
|
| KMS-28BM | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-28BM | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| KMS-28BM | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-28BM | ML030 | CTRP2 | 0.0020 | 33.0000 |
|
| KMS-28BM | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-28BM | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | ML258 | CTRP2 | 0.0041 | 66.0000 |
|
| KMS-28BM | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| KMS-28BM | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | N9-isopropylolomoucine | CTRP2 | 3.1000 | 400.0000 |
|
| KMS-28BM | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| KMS-28BM | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-28BM | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Nelarabine | CTRP2 | 0.0020 | 33.0000 |
|
| KMS-28BM | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| KMS-28BM | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | oligomycin A | CTRP2 | 0.0041 | 33.0000 |
|
| KMS-28BM | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-28BM | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Paclitaxel | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-28BM | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | PF-750 | CTRP2 | 2.1000 | 270.0000 |
|
| KMS-28BM | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| KMS-28BM | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | pifithrin-alpha | CTRP2 | 1.8000 | 230.0000 |
|
| KMS-28BM | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Platin | CTRP2 | 0.0020 | 33.0000 |
|
| KMS-28BM | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-28BM | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | RG-108 | CTRP2 | 2.1000 | 270.0000 |
|
| KMS-28BM | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| KMS-28BM | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | SCH-529074 | CTRP2 | 0.0010 | 2.1000 |
|
| KMS-28BM | Selumetinib | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-28BM | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| KMS-28BM | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| KMS-28BM | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| KMS-28BM | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| KMS-28BM | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| KMS-28BM | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| KMS-28BM | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| KMS-28BM | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| KMS-28BM | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| KMS-28BM | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| KMS-28BM | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| KMS-28BM | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| KMS-28BM | Sorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| KMS-28BM | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| KMS-28BM | Tanespimycin | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Temsirolimus | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | tipifarnib-P2 | CTRP2 | 0.0160 | 33.0000 |
|
| KMS-28BM | Tivozanib | CTRP2 | 0.0081 | 33.0000 |
|
| KMS-28BM | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| KMS-28BM | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-28BM | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| KMS-28BM | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| KMS-28BM | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | triptolide | CTRP2 | 0.0000 | 0.2900 |
|
| KMS-28BM | Tubastatin A | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | UNC0638 | CTRP2 | 0.0010 | 17.0000 |
|
| KMS-28BM | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| KMS-28BM | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| KMS-28BM | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| KMS-28BM | YK-4-279 | CTRP2 | 0.0041 | 33.0000 |
|
| KMS-28BM | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC